Ratnasiri, Kalani http://orcid.org/0000-0001-5953-0004
Wilk, Aaron J. http://orcid.org/0000-0003-1430-5852
Lee, Madeline J. http://orcid.org/0000-0001-5039-6806
Khatri, Purvesh http://orcid.org/0000-0002-4143-4708
Blish, Catherine A. http://orcid.org/0000-0001-6946-7627
Funding for this research was provided by:
NIH Office of the Director (DP1 DA045089)
Bill and Melinda Gates Foundation (OP113682, OP113682)
NIH (U19AI109662, T32 AI00729037, T32 GM007364)
NIH (F31 AI172311)
Bio-X Graduate Fellowship
National Science Foundation (2019282939)
Department of Defense (W81WXH-18-1-0253, W91XWJ10235)
Dr. Ralph and Marian Falk Medical Research Trust
Chan Zuckerberg Biohub
Article History
Received: 16 August 2022
Accepted: 31 October 2022
First Online: 21 November 2022
Declarations
:
: PK is a shareholder in Inflammatix.